Eduard Alcordo has been a Director of First Pacific Capital Underwriters since 1989. In 2021 he set up FP Paradigm Pty Ltd with a focus on impact investing, partnering with the University of New South Wales in a breakthrough sustainable packaging initiative.
Mr Alcordo was Director of the Macquarie University Foundation. He has been in t
Eduard Alcordo has been a Director of First Pacific Capital Underwriters since 1989. In 2021 he set up FP Paradigm Pty Ltd with a focus on impact investing, partnering with the University of New South Wales in a breakthrough sustainable packaging initiative.
Mr Alcordo was Director of the Macquarie University Foundation. He has been in the Australian capital markets since 1984, having worked as Executive Director at First National Securities (a subsidiary of National Australia Bank), Fay Richwhite, the Canadian Imperial Bank of Commerce and Advance Bank Australia.
Eduard has led several listed companies in Australia. He was Chairman of Asia Pacific Power and Light Limited, Qmator, and was a Director of Kolback Limited. He was actively involved in developing 18 power plants around the world, including one in Queensland powering 22,000 homes between Brisbane and the Gold Coast with green energy. He was the foundation shareholder of East Asia Power Resources with 450 megawatts, which was listed on the Philippine Stock Exchange. He was Chairman of AusBio, the allograph medical device company in New South Wales. Mr Alcordo was President of the Australia Philippines Business Council from 2012-2021.
Professor Ian Gibson has over 30 years of experience as a computer scientist and engineer and at executive level R&D management. He has led the research, development, and global commercialisation of new technology across a broad range of electrical engineering, computer science and digital imaging. Professor Gibson was the founding CEO of
Professor Ian Gibson has over 30 years of experience as a computer scientist and engineer and at executive level R&D management. He has led the research, development, and global commercialisation of new technology across a broad range of electrical engineering, computer science and digital imaging. Professor Gibson was the founding CEO of Intersect Australia Ltd (2008 - 2015). Prior to this Professor Gibson was General Manager at CiSRA, the Australian R&D lab for Canon Inc, where he built research capability over several years to deliver world-leading technology into a wide range of Canon's major product groups generating hundreds of patents along the way.
Professor Gibson's technology has been shipped in over a billion units worldwide, and he has secured over $200m in research funds from a variety of sources.
Dr Eutick has a PhD in Biochemistry from the University of Sydney and a Post-Doctoral Fellowship from Universite de Dijon, France. He was awarded the Medal of the Order of Australia for Services to Biotechnology. He is the Director of Europharma. Dr Eutick founded Phebra Limited, Australia’s largest injectable pharmaceutical company. Dr E
Dr Eutick has a PhD in Biochemistry from the University of Sydney and a Post-Doctoral Fellowship from Universite de Dijon, France. He was awarded the Medal of the Order of Australia for Services to Biotechnology. He is the Director of Europharma. Dr Eutick founded Phebra Limited, Australia’s largest injectable pharmaceutical company. Dr Eutick has also held the following positions:
Steven Commerford is an industry leader with over 20 years’ experience in Food and Beverage. Disciplines range from strategic marketing, brand development, innovation, category, sales and business development, Steven is respected for his ability to lead businesses through significant growth.
Holding a BA Commerce- Marketing (WSU) and Dip Food Technology, Steven has commercial experience across all sectors of the FMCG industry. He has experience with accelerating growth for tier-1 consumer brands such as Coca-Cola, Grinders Coffee, Dare Iced Coffee and Kettle Chips. With a passion for sustainability, Steven was part of leading the change in coffee-sourcing practices through FairTrade and initiatives to tackle key issues related to recycling of coffee packaging.
Steven is connecting industrial partners that are looking to accelerate their sustainability goals and address key sustainability issues within the plastics industry.
Hamish is an accomplished Quality Assurance and Biotech Specialist, known for his unwavering commitment to excellence, with a solid foundation in Agile methodologies, project management, and laboratory techniques. His diverse skill set encompasses quality management, troubleshooting, and meticulous documentation. His aspiration is to further advance his expertise, contributing to cutting-edge innovations in biotechnology and laboratory sciences, all while nurturing strong interpersonal connections and a collaborative workplace culture.
Hamish completed his studies of Advanced Science, Chemistry and Biomolecular Science at Macquarie University and pursued a career in Chemical analysis. His most recent role as Senior Quality Analyst with Inventia Life Science clearly demonstrates his commitment to quality assurance, risk assessment and process improvement. His strong academic and commercial acumen provide him with a fine skillset well suited to our projects.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.